AbelZeta is a global clinical-stage biopharmaceutical company with centers of excellence in Rockville, Maryland and Shanghai, China. AbelZeta is focusing on developing innovative and proprietary cell-based therapeutic products and is committed to ushering in bespoke treatments that harness the body's own immune system to fight against hematological malignancies and solid tumors, as well as inflammatory and immunological diseases. AbelZeta advances research and development in its own GMP facilities at its centers of excellence for early-stage clinical studies, with a pipeline comprised of CAR-T and TIL therapies. 

Biotechnology

Health Care

Pharmaceutical

Therapeutics

AbelZeta

Tony Liu

Cherie S.

Hui Wan

Jiaqi Huang

Andrew Chan

The Leadership Team at AbelZeta is responsible for setting the strategic vision and direction of the company, ensuring regulatory compliance, leading clinical and translational science initiatives, and overseeing legal and medical affairs. This senior group guides product development, research advancements, and the overall business operations to drive innovation in cell-based therapeutic treatments.

Leadership Team

Research and Development

Operations Team

Leadership Team

About

Team members

Other teams at AbelZeta

Research and Development

Operations Team